Published in
Taylor and Francis Group, OncoImmunology, 5(7), p. e1423184
DOI: 10.1080/2162402x.2017.1423184
Links
Tools
Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome
Journal article published in 2018 by
Véronique M. Braud 
,
Jérôme Biton,
Etienne Becht,
Samantha Knockaert,
Audrey Mansuet-Lupo,
Estelle Cosson,
Diane Damotte,
Marco Alifano,
Pierre Validire,
Fabienne Anjuère,
Isabelle Cremer,
Nicolas Girard,
Dominique Gossot,
Agathe Seguin-Givelet,
Marie-Caroline Dieu-Nosjean
and other authors.
,
Jérôme Biton,
Etienne Becht,
Samantha Knockaert,
Audrey Mansuet-Lupo,
Estelle Cosson,
Diane Damotte,
Marco Alifano,
Pierre Validire,
Fabienne Anjuère,
Isabelle Cremer,
Nicolas Girard,
Dominique Gossot,
Agathe Seguin-Givelet,
Marie-Caroline Dieu-Nosjean
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 